Bookbot
Presne táto pôjde do košíka

Progress and Controversies in Oncological Urology - 5: Renal, Bladder and Prostate Cancer

An Update

Parametre

  • 290 stránok
  • 11 hodin čítania

Viac o knihe

This is an advanced reference and clinical text documenting the latest advances and current knowledge on all aspects of diagnosing and treating renal, bladder and prostate cancer. It contains 33 original, new chapters by high-level experts in urology, oncology, endocrinology, immunohematology, and pathology from leading medical centers in the United States and Europe. Their contributions provide essential updates on today's most intensely researched and debated issues in renal, bladder and prostate cancer. These include molecular genetics, organ-sparing surgery, tumor nephrectomy, metastatic renal cell carcinoma, gene therapy, optimal strategies for early detection, accuracy of grading, avoiding aggressive treatment when unneeded, advances in radiotherapy, minimal invasive treatment alternatives, endocrine treatment, androgen monotherapy, quality of life issues, new approaches to drug development, intravesical chemotherapy, adjuvant therapy, urinary cytokines as predictors, bladder preservation, orthotopic urinary diversion, systemic treatment, and contemporary approaches for chemotherapy. Massively referenced and fully indexed.

Nákup knihy

Progress and Controversies in Oncological Urology - 5: Renal, Bladder and Prostate Cancer, Fritz H. Schröder, Gerald H. Mickisch, Karl H. Kurth

Jazyk
Rok vydania
1999
Väzba
(pevná),
Stav knihy
Dobrá
Cena
6,09 €

Doručenie

Platobné metódy

Nikto zatiaľ neohodnotil.

Titul
Progress and Controversies in Oncological Urology - 5: Renal, Bladder and Prostate Cancer
Podtitul
An Update
Jazyk
anglicky
Rok vydania
1999
Väzba
pevná
Počet strán
290
ISBN10
1850700818
ISBN13
9781850700814
Série
Anotácia
This is an advanced reference and clinical text documenting the latest advances and current knowledge on all aspects of diagnosing and treating renal, bladder and prostate cancer. It contains 33 original, new chapters by high-level experts in urology, oncology, endocrinology, immunohematology, and pathology from leading medical centers in the United States and Europe. Their contributions provide essential updates on today's most intensely researched and debated issues in renal, bladder and prostate cancer. These include molecular genetics, organ-sparing surgery, tumor nephrectomy, metastatic renal cell carcinoma, gene therapy, optimal strategies for early detection, accuracy of grading, avoiding aggressive treatment when unneeded, advances in radiotherapy, minimal invasive treatment alternatives, endocrine treatment, androgen monotherapy, quality of life issues, new approaches to drug development, intravesical chemotherapy, adjuvant therapy, urinary cytokines as predictors, bladder preservation, orthotopic urinary diversion, systemic treatment, and contemporary approaches for chemotherapy. Massively referenced and fully indexed.